References
- Bøhmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S. The association between metabolic syndrome and infarct size in patients with acute myocardial infarction. Scand J Clin Lab Invest 2010;70:287–93.
- Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403–14.
- Yilmaz MB. Metabolic syndrome and extension of coronary atherosclerosis. Int J Cardiol 2007;118:264.
- Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J 1993;126:937–45.
- Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 1991;83:739–46.
- Yilmaz MB, Biyikoglu SF, Akin Y, Guray U, Kisacik HL, Korkmaz S. Obesity is associated with impaired coronary collateral vessel development. Int J Obes Relat Metab Disord 2003;27:1541–5.
- Karadas F, Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Dogan K, Tandogan I. The effect of collateral circulation on left ventricular systolic function. Coron Artery Dis 2007;18:169–73.